Kidney disease study: can sugar levels guide better drug dosing?
NCT ID NCT07084038
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 28 times
Summary
This study looks at 300 adults with chronic kidney disease who are already taking a standard SGLT2 inhibitor. Researchers want to see if the amount of sugar in their urine is linked to changes in protein levels in their urine, which is a key marker of kidney health. The goal is to find out if sugar levels can help doctors adjust the dose of the drug for better results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA General Hospital,
Beijing, Beijing Municipality, 100853, China
Conditions
Explore the condition pages connected to this study.